Abstract PS2-11-17: Engineered EVs-mediated miR-222 targeting PTEN/FN1 axis reverses anthracycline resistance in HER2-negative breast cancer
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7129734538
Cites:
Cited by:
Related to:
